Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CXCR4 | P61073 | 9/20 | 0.61 |
| ▸ | IL23R | Q5VWK5 | 1/20 | 0.58 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.57 |
| ▸ | KISS1R | Q969F8 | 1/20 | 0.56 |
| ▸ | OPRM1 | P35372 | 4/20 | 0.54 |
| ▸ | OPRK1 | P41145 | 4/20 | 0.54 |
| ▸ | TACR1 | P25103 | 1/20 | 0.54 |
| ▸ | MC4R | P32245 | 2/20 | 0.54 |
| ▸ | MC5R | P33032 | 2/20 | 0.54 |
| ▸ | MC3R | P41968 | 2/20 | 0.54 |
| ▸ | MC1R | Q01726 | 2/20 | 0.54 |
| ▸ | NTSR2 | O95665 | 1/20 | 0.53 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.53 |
| ▸ | SORT1 | Q99523 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31452905 | 0.91 | CXCR4 (0.62) | CXCR4IL23RC5AR1KISS1ROPRM1 | |
| SCHEMBL31650786 | 0.90 | MC4R (0.64) | CXCR4IL23RC5AR1KISS1ROPRM1 | |
| SCHEMBL29476509 | 0.90 | KISS1R (0.55) | CXCR4IL23RC5AR1KISS1RNTSR2 | |
| SCHEMBL29476405 | 0.90 | KISS1R (0.55) | CXCR4IL23RC5AR1KISS1RNTSR2 | |
| SCHEMBL29697181 | 0.89 | CXCR4 (0.66) | CXCR4C5AR1KISS1ROPRM1OPRK1 | |
| SCHEMBL31378995 | 0.88 | C5AR1 (0.63) | CXCR4IL23RC5AR1KISS1RTACR1 | |
| SCHEMBL31593371 | 0.88 | CXCR4 (0.60) | CXCR4IL23RC5AR1KISS1RTACR1 | |
| SCHEMBL31187042 | 0.88 | CXCR4 (0.63) | CXCR4IL23RC5AR1KISS1RTACR1 | |
| SCHEMBL29546449 | 0.88 | C5AR1 (0.56) | CXCR4IL23RC5AR1KISS1ROPRM1 | |
| SCHEMBL29853326 | 0.87 | C5AR1 (0.63) | CXCR4IL23RC5AR1KISS1RTACR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120365374-A | Construction and activity evaluation of anti-cancer peptide inhibitor GLP3 based on Grb2 preferential binding motif | 滨州医学院 | 2025-07-25 | — | — | CN | disclosed |